Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA supplement survey

This article was originally published in The Tan Sheet

Executive Summary

National Dairy Council suggests addition of fortified food questions in agency study of consumers' knowledge and practices regarding dietary supplements. "This information will help FDA assess the need to revise and update its food fortification policy guidelines and will provide initial direction for the process," NDC says. NNFA suggests survey data on supplement adverse events "should only serve as a starting point for the agency to focus on the proper collection and evaluation of adverse experiences and not be used to malign particular products or DSHEA." FDA announced plans to conduct the survey in August (1"The Tan Sheet" Aug. 13, p. 11)

You may also be interested in...



FDA Supplement Survey Will Gauge Prevalence And Purpose Of Product Use

FDA's pending telephone survey of consumers' knowledge, beliefs and practices regarding dietary supplements will involve a nationally representative sample of 2,000 randomly selected adults.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS093130

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel